TP53 and cancer: In a previous study, the dependence of WEE1 inhibitor sensitivity on TP53 mutation status was not resolved22, thus to investigate whether TP53 mutation status was associated with WEE1 inhibitor sensitivity, we used the cancer cell line encyclopedia (CCLE) database to evaluate TP53 mutation status.